{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T22:51:12Z","timestamp":1768776672388,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.cct.2011.07.006","type":"journal-article","created":{"date-parts":[[2011,7,23]],"date-time":"2011-07-23T13:25:01Z","timestamp":1311427501000},"page":"909-915","source":"Crossref","is-referenced-by-count":34,"title":["Improving adherence using combination therapy (IMPACT): Design and protocol of a randomised controlled trial in primary care"],"prefix":"10.1016","volume":"32","clinical-trial-number":[{"clinical-trial-number":"actrn12606000067572","registry":"10.18810\/anzctr"}],"author":[{"given":"Vanessa","family":"Selak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Raina","family":"Elley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Crengle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matire","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Doughty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Arroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Rafter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen Vander","family":"Hoorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Wadham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Milne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rod","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale","family":"Bramley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2011.07.006_bb0005","series-title":"The global buden of disease: 2004 update","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.cct.2011.07.006_bb0010","series-title":"Decades of disparity: ethnic mortality trends in New Zealand 1980\u20131999","author":"Ajwani","year":"2003"},{"key":"10.1016\/j.cct.2011.07.006_bb0015","first-page":"117","article-title":"Quality and equity in cardiovascular health in New Zealand: the need for agreed achievable standards of care, cohesive planning and action","author":"Sharpe","year":"2004","journal-title":"NZ Med J"},{"key":"10.1016\/j.cct.2011.07.006_bb0020","series-title":"The burden of disease and injury in New Zealand, public health intelligence, occasional bulletin number 1","author":"Tobias","year":"2001"},{"key":"10.1016\/j.cct.2011.07.006_bb0025","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(03)12655-4","article-title":"Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovscular-disease risk","volume":"361","author":"Murray","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2011.07.006_bb0030","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/bmj.326.7404.1419","article-title":"A strategy to reduce cardiovascular disease by more than 80%","volume":"326","author":"Wald","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.cct.2011.07.006_bb0035","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0140-6736(02)09358-3","article-title":"Two decades of progress in preventing vascular disease","volume":"360","author":"Yusuf","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2011.07.006_bb0040","series-title":"Evidence-based best practice guideline. The assessment and management of cardiovascular risk","author":"New Zealand Guidelines Group","year":"2003"},{"issue":"2","key":"10.1016\/j.cct.2011.07.006_bb0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1071\/HC11093","article-title":"Under-utilisation of preventive medication in patients with cardiovascular disease is greatest in younger age groups (PREDICT-CVD 15)","volume":"3","author":"Mehta","year":"2011","journal-title":"Journal of Primary Health Care"},{"key":"10.1016\/j.cct.2011.07.006_bb0050","doi-asserted-by":"crossref","unstructured":"Thornley S, Marshall R, Chan WC, Kerr A, Harrison J, Jackson G, et al. Four out of ten patients are not taking statins regularly during the 12months after an acute coronary event. European Journal of Cardiovascular Prevention & Rehabilitation, March 14, 2011. [Epub ahead of print].","DOI":"10.1177\/1741826711403069"},{"key":"10.1016\/j.cct.2011.07.006_bb0055","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5694\/j.1326-5377.2010.tb03502.x","article-title":"Cardiovacular risk perception and evidence-practice gaps in Australian general practice (the AusHEART study)","volume":"192","author":"Heeley","year":"2010","journal-title":"Med J Aust"},{"key":"10.1016\/j.cct.2011.07.006_bb0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/HJR.0b013e3283294b1d","article-title":"EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries","volume":"16","author":"Kotseva","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.cct.2011.07.006_bb0065","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/HPC.0b013e3181b8395d","article-title":"Regional and practice variation in adherence to guideline recommendations for secondary adn primary prevention among outpatients with atherothrombosis or risk factors in the United States","volume":"8","author":"Kumar","year":"2009","journal-title":"Crit Pathw Cardiol"},{"key":"10.1016\/j.cct.2011.07.006_bb0070","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0828-282X(07)70882-6","article-title":"Missed opportunities for the secondary prevention of cardiovascular disease in Canada","volume":"23","author":"Hackam","year":"2007","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cct.2011.07.006_bb0075","unstructured":"Wells S. Getting evidence to and from general practice consultations for cardiovascular risk management using computerised decision support. PhD thesis: University of Auckland; 2008."},{"key":"10.1016\/j.cct.2011.07.006_bb0080","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0149-2918(96)80080-4","article-title":"Risk factors for antihypertensive medication refill failure by patients under Medicaid Managed Care","volume":"18","author":"Bailey","year":"1996","journal-title":"Clin Ther"},{"key":"10.1016\/j.cct.2011.07.006_bb0085","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.0306-5251.2001.01401.x","article-title":"Drug therapy in the elderly: what doctors believe and patients actually do","volume":"51","author":"Barat","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cct.2011.07.006_bb0090","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/01.CIR.95.4.1085","article-title":"Expert panel on compliance. The multilevel compliance challenge: recommendations for a call to action","volume":"95","author":"Miller","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cct.2011.07.006_bb0095","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.2337\/diacare.20.10.1512","article-title":"Impact of dosage frequency on patient compliance","volume":"20","author":"Paes","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cct.2011.07.006_bb0100","series-title":"Adherence to long-term therapies: evidence for action","author":"World Health Organization","year":"2003"},{"key":"10.1016\/j.cct.2011.07.006_bb0105","series-title":"A review of barriers to medication adherence: a framework for driving policy options","author":"Gellad","year":"2009"},{"key":"10.1016\/j.cct.2011.07.006_bb0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1472-8206.2009.00799.x","article-title":"Multiple action fixed combination. Present or future?","volume":"24","author":"Garcia-Donaire","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.cct.2011.07.006_bb0115","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1742-1241.2010.02412.x","article-title":"A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy (\u2018polypill\u2019) on cardiovascular risk factors","volume":"64","author":"Malekzadeh","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.cct.2011.07.006_bb0120","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(09)60611-5","article-title":"Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial","volume":"373","author":"The Indian Polycap Study (TIPS)","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2011.07.006_bb0125","first-page":"10","article-title":"Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk","author":"Liu","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.cct.2011.07.006_bb0130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1071\/HC10092","article-title":"Aspirin for primary prevention: yes or no?","volume":"2","author":"Selak","year":"2010","journal-title":"J Prim Health Care"},{"key":"10.1016\/j.cct.2011.07.006_bb0135","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"228","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.cct.2011.07.006_bb0140","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1161\/CIRCULATIONAHA.110.953653","volume":"123","author":"Anderson","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cct.2011.07.006_bb0145","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.107.188209","volume":"117","author":"Antman","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cct.2011.07.006_bb0150","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/eurheartj\/ehn416","article-title":"Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation","volume":"29","author":"Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cct.2011.07.006_bb0155","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","article-title":"Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 ranomised trials","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.cct.2011.07.006_bb0160","series-title":"New Zealand cardiovascular guidelines handbook: a summary resource for primary care practitioners","author":"New Zealand Guidelines Group","year":"2009"},{"key":"10.1016\/j.cct.2011.07.006_bb0165","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/archinte.165.10.1147","article-title":"Predictors of adherence with anithypertensive and lipid-lowering therapy","volume":"165","author":"Chapman","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cct.2011.07.006_bb0170","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/HYPERTENSIONAHA.109.139816","article-title":"Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis","volume":"55","author":"Gupta","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.cct.2011.07.006_bb0175","series-title":"Assessing cost-effectiveness in prevention (ACE-Prevention): final report University of Queensland","author":"Vos","year":"2010"},{"key":"10.1016\/j.cct.2011.07.006_bb0180","series-title":"NZDep2006 index of deprivation","author":"Salmond","year":"2007"},{"key":"10.1016\/j.cct.2011.07.006_bb0185","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","article-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic reivew and meta-analysis","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.cct.2011.07.006_bb0190","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","year":"2009","journal-title":"Lancet"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714411001807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714411001807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T15:09:05Z","timestamp":1592752145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714411001807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1551714411001807"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2011.07.006","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}